Answers are grounded in this paper and cite their sources.
Taken together, the data suggest that platelets are at the frontline of COVID-19 pathogenesis, as they release various sets of molecules through the different stages of the disease. Platelets may thus have the potential to contribute to the overwhelming thrombo-inflammation in COVID-19, and the inhibition of pathways related to platelet activation may improve the outcomes during COVID-19.
No takes yet. Share an insight, caveat, or question.
Zaid et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: